Scholars Central

Conference abstractPublished 20 Jun 2013

Cancer stem cells: Implications for colon carcinogenesis and development of therapeutic strategies with natural agents

Authors: Adhip P. N. Majumdar

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Recent evidence supports the contention that epithelial cancers, including sporadic colorectal cancer (CRC), the incidence of which increases with aging, are diseases driven by self-renewing cancer stem cells (CSCs). We reported an age-related increase in colon CSCs. One of the characteristics of CSCs is their resistance to 5-FU based chemotherapy, the mainstay of colon cancer therapeutic with significant toxicities, resulting in high disease recurrence underscoring the need for improved CSC-targeted non-toxic therapeutics for CRC. Investigations were carried out to examine the role of CSCs in the development of CRC during aging and to develop therapeutic strategies using natural agents to combat this malignancy. Methods: Both in vitro and in vivo studies were conducted. Immunohistochemistry and quantitative real-time PCR as well as Western- blot analysis were used to determine the relative concentration of markers of colon CSCs. Flow cytometry was utilized to examine the proportion of colon CSCs. Results: We found that curcumin, the major active ingredient of turmeric ( Curcuma longa ), used in South Asian cuisine, with no discernible toxicity synergizes with FOLFOX (5-FU + Oxaliplatin) and attenuates EGFR signaling resulting in inhibition of colon cancer cell growth. In subsequent studies, we observed that difluorinated curcumin (CDF), a novel analog of curcumin, either alone or together with FOLFOX markedly stimulates apoptosis of FOLFOX-resistant colon cancer cells and disintegrates colonospheres (surrogate tumors) that are highly enriched in CSCs. Another approach we utilized was to induce differentiation of colon CSCs by down-regulating miroRNA-21 (which is upregulated in CRC) and subjecting the differentiated/differentiating cancer cells to CDF either alone or together with 5-FU based chemotherapy treatment. This approach resulted in a marked attenuation of EGFR signaling, β-catenin/TCF driven gene transcription and reduction in colon CSCs and cellular growth. Conclusion: The conventional 5-FU based chemotherapy together with one of the following agents (a) curcumin, (b) CDF that eliminates colon CSCs could be effectively utilized for treatment of colorectal cancer. Differentiation of colon CSCs also renders the chemo-resistant cells highly susceptible to the combination of 5-FU based chemotherapy and CDF.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Gastrointestinal & Digestive System.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Gastrointestinal & Digestive System
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Adhip P. N. Majumdar”